tiprankstipranks
Trending News
More News >
2Seventy Bio, Inc. (TSVT)
NASDAQ:TSVT
US Market

2seventy bio (TSVT) Stock Statistics & Valuation Metrics

Compare
276 Followers

Total Valuation

2seventy bio has a market cap or net worth of $266.15M. The enterprise value is ―.
Market Cap$266.15M
Enterprise Value

Share Statistics

2seventy bio has 53,229,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding53,229,790
Owned by Insiders10.07%
Owned by Institutions<0.01%

Financial Efficiency

2seventy bio’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -25.33%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-25.33%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee582.49K
Profits Per Employee-880.72K
Employee Count65
Asset Turnover0.08
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of 2seventy bio is -2.68. 2seventy bio’s PEG ratio is -0.11.
PE Ratio-2.68
PS Ratio0.00
PB Ratio1.23
Price to Fair Value0.73
Price to FCF-3.02
Price to Operating Cash Flow-3.04
PEG Ratio-0.11

Income Statement

In the last 12 months, 2seventy bio had revenue of 37.86M and earned -57.25M in profits. Earnings per share was -1.10.
Revenue37.86M
Gross Profit37.86M
Operating Income-115.43M
Pretax Income-57.25M
Net Income-57.25M
EBITDA-98.45M
Earnings Per Share (EPS)-1.10

Cash Flow

In the last 12 months, operating cash flow was -85.00M and capital expenditures -707.00K, giving a free cash flow of -85.70M billion.
Operating Cash Flow-85.00M
Free Cash Flow-85.70M
Free Cash Flow per Share-1.61

Dividends & Yields

2seventy bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.42
52-Week Price Change9.65%
50-Day Moving Average4.69
200-Day Moving Average4.06
Relative Strength Index (RSI)72.25
Average Volume (3m)1.05M

Important Dates

2seventy bio upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date

Financial Position

2seventy bio as a current ratio of 4.67, with Debt / Equity ratio of 115.61%
Current Ratio4.67
Quick Ratio4.67
Debt to Market Cap1.59
Net Debt to EBITDA-1.75
Interest Coverage Ratio0.00

Taxes

In the past 12 months, 2seventy bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

2seventy bio EV to EBITDA ratio is -3.31, with an EV/FCF ratio of -3.80.
EV to Sales8.61
EV to EBITDA-3.31
EV to Free Cash Flow-3.80
EV to Operating Cash Flow-3.84

Balance Sheet

2seventy bio has $174.75M in cash and marketable securities with $243.72M in debt, giving a net cash position of $68.96M billion.
Cash & Marketable Securities$174.75M
Total Debt$243.72M
Net Cash$68.96M
Net Cash Per Share$1.30
Tangible Book Value Per Share$3.92

Margins

Gross margin is 34.84%, with operating margin of -304.87%, and net profit margin of -151.20%.
Gross Margin34.84%
Operating Margin-304.87%
Pretax Margin-151.20%
Net Profit Margin-151.20%
EBITDA Margin-260.01%
EBIT Margin-278.75%

Analyst Forecast

The average price target for 2seventy bio is $5.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.00
Price Target Upside0.00%
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast-32.07%
EPS Growth Forecast98.22%

Scores

Smart Score3
AI Score41
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis